I know of at least 2 patients of Eylea/Luvestin (??) that would pay good money not to get that injection!! Small sample size but common sense prevails (pill or injection). My concern of Optina results not meeting Eylea/Luvestin' is not very big as I believe Optina will sell in the marketplace (as long as we're not drastically under-performing those drugs)
Here's my question to you. Let's say Optina results are good but not great (not as good REGN) and we get approval from the FDA. Don't you think real world patients and their Dr's wouldn't want to try Optina (pill) 1st to see if it worked before they agree to have a needle stuck in their eye??? ANY improvement in eyesight has to be better than none. IF we get approval I think this drug sells because of the above reason
They also made a comment about the makeup of the Optina trial participants alluding to a large percentage (dont' recall the exact number) that had been on Eylea, REGN's drug, Luvestin (Not sure of all the names) and were not getting better on those drugs and therefore came to this trial
Nice call yesterday and some interesting nuggets of information affirming the excellent science behind both Ampion and Optina. Talks on-going with big Pharma and a deal comes when a deal comes. FDA is judge, jury and executioner and their opinion is the ONLY opinion that matters. Listening to prognosticating from the likes of individuals with apparent or hidden agendas is useless. We are all invested in a PRE-approved drug company and most should already understand those risks, if you don't do your homework to see examples of drug companies that get slapped down by the FDA. The stock price is completely out of our control, the process that the company is taking (garnering Institutional support) takes time to implement. In the meantine the shorts or the HFT computers make their money the old fashioned WS way. HFT Computers don't care about market potential or profit margins, they just care about how they can manipulate the market to make money. Shorts are like pigs at a trough when it comes to biotechs like AMPE. There are so many un-knowns and therefore it makes it very difficult to find fair value for pre-revenue/pre-approved bio-techs like AMPE. AF and his merry band of fraudsters spin every piece of information to suit their thesis. I'm here simply because I believe in the science and the market selling potential of both of these drugs and I believe that potential dwarfs $6, $8 or even $10 bucks. Where the stock goes from there is anyone's guess. The risk is non-approval by the FDA. The overall market appears to not be co-operating at the current time so it will probably weigh on us a little, but I tend to believe V-shaped bottoms like we saw yesterday tend to show short term bottoms on a stock. Watching the stock drop from $9.30 less than a month ago really sucked and I've been patiently looking for a bottom. My opinion is I think we may have gotten one yesterday around the $6.15 level. Good luck to everyone today.
we're in a trading range, news will move us out of it and I'm thinking it will be positive
Volume slowing down could be a signal that selling is winding down???
Of course you don't. Nothing this company does will sit well with you. Let's talk about the Yankees and why they will stink this year, maybe we can agree on that
A company that never even holds a standard quarterly CC is coming out with an investor presentation open to the public. I'm trying to understand how this can't be positive news
I don't believe they traditionally hold CC's for earnings (I'm ashamed to admit but I don't think I've listened to one over the last year). Seems they may have something important to share????
23MM shares have traded since the Feb 6th offering. My guess is a good majority of those 8.5MM secondary shares have been sold already. we'll see over the next few weeks
"board has gotten pessimistic"
Sounds like the short cabal has done their job!! Ever wonder why PHD's in psychology are on the payroll of some of these HF's and Investment Bank's trading divisions. You're supposed to react in the exact opposite manner of your feelings when contemplating buy/sell decisions in the stock market. Buy when you can't feel any worse and sell when you can't feel any better. Most of the posters here aren't day trading/swing trading their positions so why all the doom and gloom?? This stock could be at $12-$15 in a day!!! I'm going out tonight and consume too much alcohol and hit on age-inappropriate women!! Have a great weekend everyone!!
do your homework on QCOM and exactly how they got their start. They spent ALOT of time in the court room. You're wrong as usual, doesn't it get old????????
You had me at "lucasell alone", I'll believe progress on VS/FICO when I see the cold hard cash. Been here since NOV 2010 and bought into the "securing the mobile wallet" hype/trend. Bought another 30k shares today based on the phone side of the business alone, expecting nothing from VS (will gladly eat crow if anything material comes from that division). Phone side take me where I want to go
They probably don't have any NV Vault or ExpressVault agreements or customers or revenue according to your logic either!!!
Go look at the numbers turned in by our customer Nimble and then re-read the CC transcripts from SA. You will feel much more confident buying pullbacks in this stock. 2014 should be fun
completely disagree. You can't ignore the "secondary playbook" used by the short hedge funds... Short into the offering (last week stock went from $9.25 down to $7.98) and then either cover with shares on the offering or knowing their will be "flippers" of said offering to allow them ample supply to cover into. Simple dilution math could easily take you to this $7 number